Search

everythinglearnresearchcommunity

for

Search:↓

Deoxycholic acid effectively reduces double chin fat with temporary side effects and high patient satisfaction.

Spironolactone may help reduce hair loss in androgenic alopecia.

Low-level laser therapy reduces orthodontic relapse in rats, but fulvic acids do not.

Baby born healthy despite mom taking finasteride, but more research needed.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

Individualized treatment improves symptoms and quality of life for women with PCOS.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A woman's liver was damaged by taking the herbal supplement Shou-Wu-Pian, but it got better after she stopped using it.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.